-
Je něco špatně v tomto záznamu ?
Proteinase-activated Receptor 2: Springboard of Tumors
D. Vetvicka, P. Suhaj, T. Olejar, L. Sivak, J. Benes, P. Pouckova
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články, přehledy
- MeSH
- lidé MeSH
- nádory * metabolismus MeSH
- receptor PAR-1 metabolismus MeSH
- receptor PAR-2 * metabolismus MeSH
- signální transdukce fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Proteinase-activated receptors (PARs) were discovered more than 25 years ago and since then, their role in cancer has been under investigation. Research has primarily focused on the receptors located on the membrane of cancer cells and their impact on metabolism, intracellular signalling, and proliferation. Regarding the host response to cancer, studies have predominantly examined the relationship of thrombin receptors (PAR-1, PAR-3, and PAR-4) with blood clotting in distant metastatic spread. However, limited studies have examined the role of PARs, especially PAR-2, in the host anti-tumor immunity. This review article provides insights into the role of PAR-2 on cancer cells and immune competent cells involved in cancer development and progression. It also discussed the current knowledge of the importance of PAR-2 activation at various stages of cancer progression and its association with cancer-related pain.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007721
- 003
- CZ-PrNML
- 005
- 20240423160216.0
- 007
- ta
- 008
- 240412s2024 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21873/anticanres.16782 $2 doi
- 035 __
- $a (PubMed)38159988
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Vetvicka, David $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic; david.vetvicka@lf1.cuni.cz
- 245 10
- $a Proteinase-activated Receptor 2: Springboard of Tumors / $c D. Vetvicka, P. Suhaj, T. Olejar, L. Sivak, J. Benes, P. Pouckova
- 520 9_
- $a Proteinase-activated receptors (PARs) were discovered more than 25 years ago and since then, their role in cancer has been under investigation. Research has primarily focused on the receptors located on the membrane of cancer cells and their impact on metabolism, intracellular signalling, and proliferation. Regarding the host response to cancer, studies have predominantly examined the relationship of thrombin receptors (PAR-1, PAR-3, and PAR-4) with blood clotting in distant metastatic spread. However, limited studies have examined the role of PARs, especially PAR-2, in the host anti-tumor immunity. This review article provides insights into the role of PAR-2 on cancer cells and immune competent cells involved in cancer development and progression. It also discussed the current knowledge of the importance of PAR-2 activation at various stages of cancer progression and its association with cancer-related pain.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a receptor PAR-2 $x metabolismus $7 D044464
- 650 12
- $a nádory $x metabolismus $7 D009369
- 650 _2
- $a receptor PAR-1 $x metabolismus $7 D044463
- 650 _2
- $a signální transdukce $x fyziologie $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Suhaj, Petr $u Department of Pathology and Molecular Medicine, Third Medical Faculty, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Olejar, Tomas $u Department of Pathology and Molecular Medicine, Third Medical Faculty, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Sivak, Ladislav $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic
- 700 1_
- $a Benes, Jiri $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Pouckova, Pavla $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 44, č. 1 (2024), s. 1-12
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38159988 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160212 $b ABA008
- 999 __
- $a ok $b bmc $g 2081605 $s 1217488
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 44 $c 1 $d 1-12 $e - $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
- LZP __
- $a Pubmed-20240412
